Susquehanna International Group, LLP Theravance Biopharma, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 11,104 shares of TBPH stock, worth $105,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,104

Previous 15,199 26.94%

Holding current value

$105,710

Previous $128,000 30.47%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.66 - $10.25 $31,367 - $41,973	-4,095 Reduced 26.94%	11,104 $89,000
Q2 2024 Aug 15, 2024	BUY	$8.29 - $9.92 $125,999 - $150,774	15,199 New	15,199 $128,000
Q4 2023 Feb 14, 2024	BUY	$8.58 - $11.4 $115,718 - $153,751	13,487 Added 33.91%	53,263 $598,000
Q3 2023 Nov 14, 2023	BUY	$8.38 - $10.44 $6,251 - $7,788	746 Added 1.91%	39,776 $343,000
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $124,785 - $146,401	-12,282 Reduced 23.94%	39,030 $403,000
Q1 2023 May 16, 2023	SELL	$9.87 - $11.44 $1.21 Million - $1.41 Million	-122,906 Reduced 70.55%	51,312 $556,000
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $758,837 - $891,732	78,636 Added 82.27%	174,218 $1.95 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $525,750 - $640,426	62,664 Added 190.36%	95,582 $969,000
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $275,520 - $338,748	-32,761 Reduced 49.88%	32,918 $298,000
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $1.52 Million - $2.37 Million	-182,782 Reduced 73.57%	65,679 $628,000
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $407,669 - $607,109	54,942 Added 28.39%	248,461 $2.75 Million
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $1.24 Million - $2.63 Million	182,438 Added 1646.4%	193,519 $1.43 Million
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $372,622 - $504,504	-25,025 Reduced 69.31%	11,081 $197,000
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $139,307 - $211,833	9,419 Added 35.29%	36,106 $534,000
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $199,898 - $297,232	9,685 Added 56.96%	26,687 $560,000
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $303,315 - $530,632	17,002 New	17,002 $393,000
Q4 2019 Feb 14, 2020	SELL	$16.12 - $25.89 $597,487 - $959,612	-37,065 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.51 - $23.78 $18,474 - $26,609	1,119 Added 3.11%	37,065 $722,000
Q2 2019 Aug 16, 2019	BUY	$15.6 - $25.15 $53,554 - $86,339	3,433 Added 10.56%	35,946 $587,000
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $360,188 - $580,688	23,089 Added 245.0%	32,513 $531,000
Q4 2018 Feb 14, 2019	BUY	$22.52 - $35.07 $212,228 - $330,499	9,424 New	9,424 $241,000
Q1 2018 May 15, 2018	SELL	$23.37 - $29.71 $709,489 - $901,965	-30,359 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$25.82 - $35.66 $783,869 - $1.08 Million	30,359	30,359 $846,000

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $636M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Theravance Biopharma, Inc. Transaction History